Trademark: 88802663
Word
LUMIVANCE
Status
Registered
Status Code
700
Status Date
Tuesday, March 2, 2021
Serial Number
88802663
Registration Number
6280320
Registration Date
Tuesday, March 2, 2021
Mark Type
4000
Filing Date
Wednesday, February 19, 2020
Published for Opposition
Tuesday, December 15, 2020

Trademark Owner History
Commave Therapeutics SA - Original Registrant

Classifications
5 pharmaceutical products for the treatment of attention deficit and hyperactivity disorder (ADHD)

Trademark Events
Jul 20, 2021
Teas Change Of Correspondence Received
Jul 20, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 2, 2021
Registered-Principal Register
Dec 15, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2020
Published For Opposition
Nov 25, 2020
Notification Of Notice Of Publication E-Mailed
Nov 6, 2020
Approved For Pub - Principal Register
Nov 6, 2020
Notification Of Non-Final Action E-Mailed
Nov 6, 2020
Non-Final Action E-Mailed
Nov 6, 2020
Non-Final Action Written
Nov 5, 2020
Teas/Email Correspondence Entered
Nov 5, 2020
Correspondence Received In Law Office
Oct 30, 2020
Teas Response To Office Action Received
Jun 10, 2020
Notification Of Non-Final Action E-Mailed
Jun 10, 2020
Non-Final Action E-Mailed
Jun 10, 2020
Non-Final Action Written
Jun 5, 2020
Teas/Email Correspondence Entered
Jun 5, 2020
Correspondence Received In Law Office
Jun 2, 2020
Teas Response To Office Action Received
May 11, 2020
Notification Of Non-Final Action E-Mailed
May 11, 2020
Non-Final Action E-Mailed
May 11, 2020
Non-Final Action Written
May 8, 2020
Assigned To Examiner
Mar 9, 2020
Preliminary/Voluntary Amendment - Entered
Feb 29, 2020
Assigned To Lie
Feb 25, 2020
Teas Voluntary Amendment Received
Feb 24, 2020
New Application Office Supplied Data Entered In Tram
Feb 22, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24